Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.
about
Single dose novel Salmonella vaccine enhances resistance against visceralizing L. major and L. donovani infection in susceptible BALB/c miceIdentification and molecular characterization of a gene encoding a protective Leishmania amazonensis Trp-Asp (WD) protein.Transgenic, fluorescent Leishmania mexicana allow direct analysis of the proteome of intracellular amastigotes.Comparison of BCG, MPL and cationic liposome adjuvant systems in leishmanial antigen vaccine formulations against murine visceral leishmaniasis.Leishmaniasis: current status of vaccine developmentProtection against cutaneous leishmaniasis induced by recombinant antigens in murine and nonhuman primate models of the human disease.Immunization with a polyprotein vaccine consisting of the T-Cell antigens thiol-specific antioxidant, Leishmania major stress-inducible protein 1, and Leishmania elongation initiation factor protects against leishmaniasis.Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?A review of adjuvants for Leishmania vaccine candidates.Development of a leishmaniasis vaccine: the importance of MPL.Recent advances in vaccines for leishmaniasis.Challenges facing adjuvants for cancer immunotherapy.Adjuvants for Leishmania vaccines: from models to clinical application.DNA immunization with the gene encoding P4 nuclease of Leishmania amazonensis protects mice against cutaneous LeishmaniasisMechanisms of immune evasion in leishmaniasisReduced infectivity of a Leishmania donovani biopterin transporter genetic mutant and its use as an attenuated strain for vaccination.
P2860
Q27305906-791FCBB5-3577-4617-9B85-13CD831D0131Q33200061-4993B7A2-896F-4B8A-BBF4-184308D86790Q33334019-CEDD25F8-2EC9-435B-BE0A-BF38A2EEFE2DQ33615236-DEDA39E5-2A10-42AC-BA80-E0667F00841BQ33941719-B7AC1133-4F5F-4457-A69E-8772FB1E3070Q34008104-B3D24F9B-BB56-4333-822B-52091C061B1EQ34128082-BC2AD989-23DC-49B9-AAE8-B0EA28A6BF57Q34347500-53A0C876-29BF-4C29-88F2-DB06307AD77DQ34647684-7726B4A0-45A1-4B66-A148-73D47D5FE02FQ35192190-7C089A18-C580-4D2E-A646-2B2C2DEF0605Q35873792-5BB26FE5-6F34-47DB-9CBF-6695BEC2DB47Q35953773-9D2A8B45-923C-4799-8F10-524FFD628A6BQ36021357-F91369EB-15A2-4218-94A4-C022F47ABE57Q36376098-BE65DDA4-04A8-4437-ADB9-233018E287B2Q36969164-034F8504-D7CB-44DA-9DA2-D8DA65248E02Q39653564-81C75178-A807-4599-AA09-3D737F952904
P2860
Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants.
description
2000 nî lūn-bûn
@nan
2000 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մարտին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@ast
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@en
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@nl
type
label
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@ast
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@en
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@nl
prefLabel
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@ast
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@en
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@nl
P2093
P2860
P1476
Subunit vaccination of mice ag ...... amastigotes and six adjuvants.
@en
P2093
P2860
P304
P356
10.1128/IAI.68.3.1328-1336.2000
P407
P577
2000-03-01T00:00:00Z